A review of prospective studies regarding percutaneous peripheral nerve stimulation treatment in the management of chronic pain

Conventionally, peripheral nerve stimulation (PNS) for treatment of chronic pain has involved a two-stage process: a short-term (e.g., 7 days) trial and, if significant pain relief is achieved, a permanent PNS system is implanted. A percutaneous PNS treatment is now available where a coiled lead may...

Full description

Saved in:
Bibliographic Details
Published inPain management Vol. 14; no. 4; p. 209
Main Authors Pritzlaff, Scott G, Latif, Usman, Rosenow, Joshua M, Chae, John, Wilson, Richard D, Huffman, William J, Crosby, Nathan D, Boggs, Joseph W
Format Journal Article
LanguageEnglish
Published England 02.04.2024
Subjects
Chronic Pain - therapy
Humans
Pain Management - methods
Peripheral Nerves - physiopathology
Prospective Studies
Transcutaneous Electric Nerve Stimulation - methods
Treatment Outcome
patient-reported outcomes
chronic pain
neuropathic pain
low back pain
percutaneous PNS
shoulder pain
peripheral nerve stimulation
Online AccessGet more information

Cover

More Information
Summary:Conventionally, peripheral nerve stimulation (PNS) for treatment of chronic pain has involved a two-stage process: a short-term (e.g., 7 days) trial and, if significant pain relief is achieved, a permanent PNS system is implanted. A percutaneous PNS treatment is now available where a coiled lead may be implanted for up to 60 days with the goal of producing sustained relief. In the present review, published prospective trials using percutaneous PNS treatment were identified and synthesized. The collected evidence indicates that percutaneous PNS treatment for up to 60 days provides durable clinically significant improvements in pain and pain interference. Similar efficacy across diverse targets and etiologies supports the broad applicability for use within the chronic pain population using this nonopioid technology.
ISSN:1758-1877
DOI:10.1080/17581869.2024.2352398